Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Keros Therapeutics, Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-04-13
Purchase
2023-01-20
4:32 pm
Keros Therapeutics Inc.KROSKnowles Julius
Director
1,191$20.98$24,987575,492
(Indirect
Direct)
View
2022-07-15
Sale
2022-07-19
4:40 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
46,034$30$1,381,020103,855
(Direct)
View
2022-07-13
Sale
2022-07-15
4:40 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
1,916$30$57,480149,889
(Direct)
View
2022-05-11
Sale
2022-05-13
4:37 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$41.9$222,050151,805
(Direct)
View
2022-04-11
Sale
2022-04-13
4:36 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$62.77$332,705157,105
(Direct)
View
2022-04-06
Sale
2022-04-08
4:21 pm
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$65$112,3208,002
(Direct)
View
2022-04-04
Sale
2022-04-06
4:49 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
7,950$60$477,000162,405
(Direct)
View
2022-04-01
Sale
2022-04-05
4:31 pm
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$57.49$49,6759,730
(Direct)
View
2022-03-11
Sale
2022-03-15
4:37 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$53.38$141,449170,355
(Direct)
View
2022-02-11
Sale
2022-02-15
4:26 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$52.06$137,965173,005
(Direct)
View
2022-01-11
Sale
2022-01-13
4:39 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$53.75$142,447175,655
(Direct)
View
2022-01-05
Sale
2022-01-07
4:35 pm
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$60$159,000178,305
(Direct)
View
2022-01-03
Sale
2022-01-05
7:14 pm
Keros Therapeutics Inc.KROSKnowles Julius
Director
47,651$57.84$2,756,116232,727
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-01
Option Award
2023-05-03
4:45 pm
N/A
2033-04-30
Keros Therapeutics Inc.KROSSeth Alpna
Director
20,000$020,000
(Direct)
View
2023-04-08
Exercise
2023-04-11
4:05 pm
N/A
2029-06-18
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
4,000$0297,943
(Direct)
View
2023-04-08
Exercise
2023-04-11
4:05 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
4,000$0.48297,943
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:19 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
100,000$0100,000
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:15 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSCooper Simon Peter
Chief Medical Officer
40,000$040,000
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:14 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSRegnante Keith
Chief Financial Officer
40,000$040,000
(Direct)
View
2023-02-16
Option Award
2023-02-17
4:13 pm
N/A
2033-02-15
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
200,000$0200,000
(Direct)
View
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
N/A
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:42 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
7,176$01,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:40 pm
N/A
N/A
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:40 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
7,176$01,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:38 pm
N/A
N/A
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
7,176$0.00011,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:38 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
7,176$01,226,412
(Indirect)
View

Ownership(A)
2022-11-30
4:37 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSPontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
0$07,176
(Indirect)
View

Ownership(A)
2022-11-30
4:36 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
0$07,176
(Indirect)
View

Ownership(A)
2022-11-30
4:34 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
0$07,176
(Indirect)
View
2022-07-15
Exercise
2022-07-19
4:40 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
46,034$0103,855
(Direct)
View
2022-07-15
Exercise
2022-07-19
4:40 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
46,034$0.3103,855
(Direct)
View
2022-07-13
Exercise
2022-07-15
4:40 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
1,916$0149,889
(Direct)
View
2022-07-13
Exercise
2022-07-15
4:40 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
1,916$0.3149,889
(Direct)
View
2022-06-14
Exercise
2022-06-14
6:57 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
9,400$0151,805
(Direct)
View
2022-06-14
Exercise
2022-06-14
6:57 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
9,400$0.3151,805
(Direct)
View
2022-06-09
Exercise
2022-06-10
4:12 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
5,000$0257,678
(Direct)
View
2022-06-09
Exercise
2022-06-10
4:12 pm
N/A
N/A
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
5,000$0.3257,678
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:30 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSNussbaum Ran
Director
10% Owner
8,293$08,293
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:28 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSKnowles Julius
Director
8,293$08,293
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:27 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
8,293$08,293
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:26 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSGRAY MARY ANN
Director
8,293$08,293
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:25 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSGORDON CARL L
Director
8,293$08,293
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:24 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSFarzan Nima
Director
8,293$08,293
(Direct)
View
2022-05-11
Exercise
2022-05-13
4:37 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$0151,805
(Direct)
View
2022-05-11
Exercise
2022-05-13
4:37 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$0.3151,805
(Direct)
View
2022-04-11
Exercise
2022-04-13
4:36 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$0157,105
(Direct)
View
2022-04-11
Exercise
2022-04-13
4:36 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
5,300$0.3157,105
(Direct)
View
2022-04-06
Exercise
2022-04-08
4:21 pm
N/A
2030-04-07
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$08,002
(Direct)
View
2022-04-06
Exercise
2022-04-08
4:21 pm
N/A
N/A
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
1,728$168,002
(Direct)
View
2022-04-04
Exercise
2022-04-06
4:49 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
7,950$0162,405
(Direct)
View
2022-04-04
Exercise
2022-04-06
4:49 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
7,950$0.3162,405
(Direct)
View
2022-04-01
Exercise
2022-04-05
4:31 pm
N/A
2030-04-07
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$09,730
(Direct)
View
2022-04-01
Exercise
2022-04-05
4:31 pm
N/A
N/A
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
864$169,730
(Direct)
View
2022-03-11
Exercise
2022-03-15
4:37 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0170,355
(Direct)
View
2022-03-11
Exercise
2022-03-15
4:37 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0.3170,355
(Direct)
View
2022-02-11
Exercise
2022-02-15
4:26 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0173,005
(Direct)
View
2022-02-11
Exercise
2022-02-15
4:26 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0.3173,005
(Direct)
View
2022-02-01
Option Award
2022-02-03
4:45 pm
N/A
2032-01-31
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
100,000$0100,000
(Direct)
View

Ownership
2022-02-03
4:37 pm
N/A
2029-09-18
Keros Therapeutics Inc.KROSRovaldi Christopher
Chief Operating Officer
0$032,898
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:17 pm
N/A
2032-01-20
Keros Therapeutics Inc.KROSSeehra Jasbir
Chief Executive Officer
165,000$0165,000
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:15 pm
N/A
2032-01-20
Keros Therapeutics Inc.KROSRegnante Keith
Chief Financial Officer
50,000$050,000
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:14 pm
N/A
2032-01-20
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
50,000$050,000
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:12 pm
N/A
2032-01-20
Keros Therapeutics Inc.KROSCooper Simon Peter
Chief Medical Officer
50,000$050,000
(Direct)
View
2022-01-11
Exercise
2022-01-13
4:39 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0175,655
(Direct)
View
2022-01-11
Exercise
2022-01-13
4:39 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0.3175,655
(Direct)
View
2022-01-05
Exercise
2022-01-07
4:35 pm
N/A
2028-03-25
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0178,305
(Direct)
View
2022-01-05
Exercise
2022-01-07
4:35 pm
N/A
N/A
Keros Therapeutics Inc.KROSLachey Jennifer
Chief Scientific Officer
2,650$0.3178,305
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next